A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial

Larry W. Moreland; James R. O'Dell; Harold E. Paulus; Jeffrey R. Curtis; Joan M. Bathon; E. William St.clair; S. Louis Bridges; Jie Zhang; Theresa McVie; George Howard; Désirée Van Der Heijde; Stacey S. Cofield

doi:10.1002/art.34498

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial

Larry W. Moreland, James R. O'Dell, Harold E. Paulus, Jeffrey R. Curtis, Joan M. Bathon, E. William St.clair, S. Louis Bridges, Jie Zhang, Theresa McVie, George Howard, Désirée Van Der Heijde, Stacey S. Cofield

Research output: Contribution to journal › Article › peer-review

277 Scopus citations

Abstract

Objective To assess whether it is better to intensively treat all patients with early rheumatoid arthritis (RA) using combinations of drugs or to reserve this approach for patients who do not have an appropriate response (as determined by a Disease Activity Score in 28 joints using the erythrocyte sedimentation rate [DAS28-ESR] of

Original language	English (US)
Pages (from-to)	2824-2835
Number of pages	12
Journal	Arthritis and Rheumatism
Volume	64
Issue number	9
DOIs	https://doi.org/10.1002/art.34498
State	Published - Sep 2012
Externally published	Yes

ASJC Scopus subject areas

Immunology
Immunology and Allergy
Rheumatology
Pharmacology (medical)

Access to Document

10.1002/art.34498

Fingerprint

Dive into the research topics of 'A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial'. Together they form a unique fingerprint.

Cite this

Moreland, L. W., O'Dell, J. R., Paulus, H. E., Curtis, J. R., Bathon, J. M., St.clair, E. W., Bridges, S. L., Zhang, J., McVie, T., Howard, G., Van Der Heijde, D., & Cofield, S. S. (2012). A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial. Arthritis and Rheumatism, 64(9), 2824-2835. https://doi.org/10.1002/art.34498

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial. / Moreland, Larry W.; O'Dell, James R.; Paulus, Harold E. et al.
In: Arthritis and Rheumatism, Vol. 64, No. 9, 09.2012, p. 2824-2835.

Research output: Contribution to journal › Article › peer-review

Moreland, LW, O'Dell, JR, Paulus, HE, Curtis, JR, Bathon, JM, St.clair, EW, Bridges, SL, Zhang, J, McVie, T, Howard, G, Van Der Heijde, D & Cofield, SS 2012, 'A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial', Arthritis and Rheumatism, vol. 64, no. 9, pp. 2824-2835. https://doi.org/10.1002/art.34498

@article{eb9dd8847c024720af1548e501481851,

title = "A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial",

abstract = "Objective To assess whether it is better to intensively treat all patients with early rheumatoid arthritis (RA) using combinations of drugs or to reserve this approach for patients who do not have an appropriate response (as determined by a Disease Activity Score in 28 joints using the erythrocyte sedimentation rate [DAS28-ESR] of ",

author = "Moreland, {Larry W.} and O'Dell, {James R.} and Paulus, {Harold E.} and Curtis, {Jeffrey R.} and Bathon, {Joan M.} and St.clair, {E. William} and Bridges, {S. Louis} and Jie Zhang and Theresa McVie and George Howard and {Van Der Heijde}, D{\'e}sir{\'e}e and Cofield, {Stacey S.}",

year = "2012",

month = sep,

doi = "10.1002/art.34498",

language = "English (US)",

volume = "64",

pages = "2824--2835",

journal = "Arthritis and Rheumatism",

issn = "0004-3591",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis

T2 - The treatment of early aggressive rheumatoid arthritis trial

AU - Moreland, Larry W.

AU - O'Dell, James R.

AU - Paulus, Harold E.

AU - Curtis, Jeffrey R.

AU - Bathon, Joan M.

AU - St.clair, E. William

AU - Bridges, S. Louis

AU - Zhang, Jie

AU - McVie, Theresa

AU - Howard, George

AU - Van Der Heijde, Désirée

AU - Cofield, Stacey S.

PY - 2012/9

Y1 - 2012/9

N2 - Objective To assess whether it is better to intensively treat all patients with early rheumatoid arthritis (RA) using combinations of drugs or to reserve this approach for patients who do not have an appropriate response (as determined by a Disease Activity Score in 28 joints using the erythrocyte sedimentation rate [DAS28-ESR] of

AB - Objective To assess whether it is better to intensively treat all patients with early rheumatoid arthritis (RA) using combinations of drugs or to reserve this approach for patients who do not have an appropriate response (as determined by a Disease Activity Score in 28 joints using the erythrocyte sedimentation rate [DAS28-ESR] of

UR - http://www.scopus.com/inward/record.url?scp=84865655947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865655947&partnerID=8YFLogxK

U2 - 10.1002/art.34498

DO - 10.1002/art.34498

M3 - Article

C2 - 22508468

AN - SCOPUS:84865655947

SN - 0004-3591

VL - 64

SP - 2824

EP - 2835

JO - Arthritis and Rheumatism

JF - Arthritis and Rheumatism

IS - 9

ER -

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The treatment of early aggressive rheumatoid arthritis trial

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this